Medical and Pharmaceutical

The Median system reported 93.3 per cent sensitivity and 92.4 per cent specificity when identifying malignant lung nodules

'Aletta' uses AI and 3D ultrasound guidance for proper placement of a robotic needle

MiniMed makes insulin delivery and glucose monitoring devices

The company is planning an NDA submission for its flagship drug as a Babesiosis treatment

The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes

Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment

Its MedTech Commercialisation Advancement Program has been expediting the tool's development

Researchers think combining both drugs could create stronger and longer-lasting tumor responses

'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it

It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease

Shares surged by 16% after the deal was announced

The research focused on hematopoietic stem cells, often called HSCs

The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment

Median secured FDA 510(k) approval for eyonis LCS on Feb. 9

The slide comes in tandem with financial results that beat expectations

The FDA grants Breakthrough Device status to a limited group of technologies

Cell therapies have gained ground in recent years as doctors turn patients’ immune systems into “living drugs.”

The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation

Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample

News comes after the company attained RMAT designation from the FDA for its lung cancer drug

The ctDNA blood draw is known for its ultrasensitive detection capabilities

In mouse experiments using human breast cancer tumors, the results were striking

News of the upcoming debut came the day before World Cancer Day, Feb. 4

Researchers at the International Agency for Research on Cancer examined data from 185 countries to quantify preventable cancer risk

It has demonstrated exceptional early-stage detection capabilities

Fox Chase Cancer Center will be leading a multi-year clinical study assessing SpotitEarly's lung cancer test

Shares rose by more than 115% on the back of the news

Optellum's AI detects nodules and Intuitive Surgical's device performs a precision biopsy

The SecureFlex needle supports endoscopic ultrasound-guided fine needle biopsy

One widely cited study was apparently relying on data from Japanese atomic bomb survivors

Corvus strengthened its balance sheet by pricing an upsized public offering

Artificial intelligence has been transforming healthcare in many regards

BioMark’s accepted paper describes a predictive model built on metabolomic pathway data rather than single biomarkers

The pilot campaign launched in 2025 with €4.9 million in backing from the Irish Cancer Society

Those models should help Merck develop virtual cell systems that better predict which diseases drugs may treat

Indian market researcher says medical diagnostics segment dominated breath analysis tech market last year

The work came from scientists at the University of Southampton’s Centre for Cancer Immunology

Their new initiative originally focused on colorectal cancer and has now expanded to lung

By doing so, the nation seeks to reduce the burden on its healthcare sector

The team gained new insight into why verticillin A resisted previous efforts